Physician profile
Robert C Middleton
NPI 1124175930
$3,421.63
in general payments reported to CMS, 2019-2025
16 companies · $294 in 2025
The $294 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $201 · 2021: $535 · 2022: $386 · 2023: $346 · 2024: $742 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $911.23 | 2019-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $527.15 | 2020-2025 | Bexsero, Pediarix |
| Supernus Pharmaceuticals, INC. | $460.45 | 2023-2024 | Qelbree, Qelbree |
| Pfizer INC. | $443.68 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $260.86 | 2019-2024 | Jornay Pm |
| Corium, LLC | $222.93 | 2021-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $215.50 | 2019-2025 | Enflonsia, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $91.23 | 2021-2025 | Doc Band |
| Aytu Biopharma, INC. | $69.45 | 2024-2025 | Karbinal |
| Integra Lifesciences Corporation | $67.60 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sanofi Pasteur INC. | $39.38 | 2019 | |
| Verrica Pharmaceuticals INC. | $29.90 | 2024 | Ycanth |
| Rhodes Pharmaceuticals L.P. | $28.58 | 2019 | |
| Alk-Abello, INC | $21.60 | 2025 | Neffy |
| Millicent US INC | $16.18 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $15.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Middleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.